Clinical trials: Lipoprotein (a)
Dyslipidemias
Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia
The present research will help to assess the effect of virgin coconut oil on cholesterol level and also will help to know whether virgin coconut oil can reduce the risk of heart diseases or not.
- Trial name
- NCT03906539
- Testing
- Atorvastatin 10mg, Virgin Coconut Oil (VCO)
- Where
- India
- Volunteers
- 150 people
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
Coronary Disease, Cardiovascular Diseases
Prospective Russian Evaluation of Lp(a) Role in cardiovascUlar DiseasE
The purpose of this study is to explore the role of lipoprotein(a) and apolipoprotein(a) phenotype in fatal and non-fatal cardiovascular disease (CVD) events risk in coronary disease patients divided on the basis of management…
- Trial name
- PRELUDE (NCT02515747)
- Testing
- percutaneous coronary intervention, coronary artery bypass grafting
- Volunteers
- 1,400 people
- Sponsor
- Russian Cardiology Research and Production Center
Atherosclerosis, Coronary Disease
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
To evaluate whether specific lipoprotein(a) apheresis on the top of optimal medical therapy could affect atherosclerotic disease burden in coronary and carotid arteries of coronary heart disease patients with elevated Lp(a)…
- Conditions
- Atherosclerosis, Coronary Disease, Carotid Artery Diseases
- Trial name
- LaRCA (NCT02133807)
- Testing
- Specific Lp(a) apheresis
- Where
- Russia
- Volunteers
- 32 people
- Sponsor
- Russian Cardiology Research and Production Center
Hypercholesterolemia
A Real-world Study to Assess the Characteristics and Long-term Effectiveness of Inclisiran in Chinese Adult Patients
This was a single-center, retrospective, observational study (non-interventional study with secondary use of data) among patients in a real-world setting. This study used the medical record data from patients in Yiling.
- Trial name
- NCT06595069
- Where
- United States
- Volunteers
- 600 people
- Sponsor
- Novartis